Terry Sharrer's bio:

Dr. Sharrer began as Executive Director, Medical Innovation and Transformation Institute, with the Inova Health System (Fairfax, VA) in July 2007. Formerly, he was the Curator of Health Sciences at the National Museum of American History, Smithsonian Institution, where he had worked for thirty-six years.

Terry Sharrer speaks and writes about a range of life science subjects. In 1987, he co-organized an exhibition titled "The Search for Life: Genetic Technology in the 20th Century." This show also was the inaugural exhibition for the DNA Learning Center at Cold Spring Harbor Laboratory in New York. He has done video documentaries on the Human Genome Project, the beginning of gene therapy, and the molecular biology of cancer. He holds a PhD in history from the University of Maryland, has authored some three dozen publications-including A Kind of Fate, Agricultural Change in Virginia, 1861-1920 (about the biological consequences of the Civil War and the beginning of germ theory practices, Iowa State University Press, 2000)-and currently is writing a history of molecular medicine. For outreach work, has served as Chairman of the Board of Directors of the National Foundation for Cancer Research (Bethesda, MD), board member of the Carilion Biomedical Institute (Roanoke, VA), board member, Immune Deficiency Foundation (Towson, MD), and board member, Inova Fairfax Hospital Cancer Advisory Committee (Fairfax, VA).

Currently, his public service includes: board member of the Fund for Inherited Disease Research (Bryn Mawr, PA); and Science Advisor, for the Loudoun County, VA Department of Economic Development, the Clarke County VA Education Foundation, and the Arizona Science Alliance. With his wife Patty, and sons Alex, age 13, and Nicholas, age 17, he lives in Hamilton, Loudoun County, VA.

Disclosure: G. Terry Sharrer, PhD has stock dividends in Merck and Pfizer.

Terry Sharrer's posts:

Why the Body Rejects Implant

November 28, 2023 | | Posted in Newsletter

Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells
“Here we [at the University of Arizona [MORE]

Electromagnetic Fields Target Glioblastoma

November 28, 2023 | | Posted in Newsletter

Researchers employ quantum mechanics to target glioblastoma
“Groundbreaking research from the University of Nottingham in the U.K. has shown how the [MORE]

AI Predicts Success of Deep Brain Stimulation for Depression

November 28, 2023 | | Posted in Newsletter

MEDTECH AI uncovers biomarker to predict deep brain stimulation successes in depression- NIH study
“To find the biomarker, the scientists used [MORE]

Implant Produces Oxygen in Islet Strategy for Diabetes

November 28, 2023 | | Posted in Newsletter

Diabetes-treating implant produces oxygen to support islet cells
“Seeking a longer-term alternative, a team from MIT and Boston Children’s Hospital recently [MORE]

AI-Driven Autonomous Needle in Treating Lung Cancer

November 28, 2023 | | Posted in Newsletter

AI-driven autonomous needle robot aims to revolutionize lung cancer treatment
“The technology in question consists of autonomous steerable needle robots each [MORE]

Dozens of Biomarkers in One Test

November 28, 2023 | | Posted in Newsletter

DNA barcoding allows nanopore sequencing to identify dozens of biomarkers in one test
“Researchers at Imperial College London (ICL) working with [MORE]

The Number of Cells in a Human

November 28, 2023 | | Posted in Newsletter

New study provides an answer to how many cells are in the human body
“According to a new analysis of more [MORE]


November 21, 2023 | | Posted in Newsletter

CRISPR-Based editing of RNA viruses developed
“A new method of genome manipulation can rapidly engineer RNA viruses through precise cleavage and [MORE]

Xenotransplant of Pig Kidney and Thymus

November 21, 2023 | | Posted in Newsletter

Xenotransplanted kidney-plus-thymus
“Surgeons at NYU Langone Medical Center tracked the activity of United Therapeutics’ UThymoKidney—a manufactured kidney that also contains a [MORE]

Stem Cells for Relapsing-Remitting MS

November 21, 2023 | | Posted in Newsletter

Stem cell transplantation suitable for treating relapsing-remitting MS
“New research led by investigators at Uppsala University in Sweden shows emerging evidence [MORE]

Handheld Device for Protein Sequencing

November 21, 2023 | | Posted in Newsletter

Professor of Chemical Biology Giovanni Maglia
“There has been a real race among scientists to create a technology that enables easy [MORE]

A “Brain Pacemaker” for Depression

November 21, 2023 | | Posted in Newsletter

Motif Neurotech successfully implants pea-sized ‘brain pacemaker’ for depression
Neurostimulation has been proven to help relieve symptoms of major depressive disorder—including [MORE]

Ageing Blood for Organ Transplants

November 21, 2023 | | Posted in Newsletter

Extended RBC storage linked to reduced risk of transplant failure in kidney transplant recipients
“In this study, longer RBC storage duration [MORE]

Tear Drop Test for Parkinson’s

November 21, 2023 | | Posted in Newsletter

Tear drop test is first rapid, point-of-care diagnostic for Parkinson’s Disease
“AXIM Biotechnologies, a developer of rapid tear drop-based diagnostics, announced [MORE]